United States District Court for the District of Columbia
April 22, 2005.
IN RE LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION. This document relates to: HEALTH CARE SERVICE CORPORATION, Plaintiff,
MYLAN LABORATORIES, INC., et al., Defendants, and BLUE CROSS BLUE SHIELD OF MINNESOTA, et al., Plaintiffs, v. MYLAN LABORATORIES, INC., et al., Defendants.
The opinion of the court was delivered by: JOHN FACCIOLA, Magistrate Judge
Pursuant to the accompanying Memorandum Opinion, it is, hereby,
ORDERED that each of the parties submit, by April 27, 2005,
revised exhibit lists in which they have eliminated all exhibits
that either I or Chief Judge Hogan have ruled inadmissible. I
shall thereafter resolve any remaining controversies.
© 1992-2005 VersusLaw Inc.